Key result
Autophagy disorder is a key pathological mechanism in polycystic ovary syndrome and serves as a potential target for therapies such as lifestyle intervention, melatonin, vitamin D, and probiotics.
Why the study?
The study was conducted to explore the relationship between autophagy and the pathological mechanism of PCOS, and to identify potential therapeutic methods targeting autophagy.
Autophagy disorder is a key pathological mechanism in PCOS and represents a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Autophagy may be a PCOS therapy target; hypothesis-generating from Level 5 evidence only.
The main purpose of this article is to explore the relationship between autophagy and the pathological mechanism of PCOS, and to find potential therapeutic methods that can alleviate the pathological mechanism of PCOS by targeting autophagy. Relevant literatures were searched in the following databases, including: PubMed, MEDLINE, Web of Science, Scopus. The search terms were "autophagy", "PCOS", "polycystic ovary syndrome", "ovulation", "hyperandrogenemia", "insulin resistance", "inflammatory state", "circadian rhythm" and "treatment", which were combined according to the retrieval methods of different databases. Through analysis, we uncovered that abnormal levels of autophagy were closely related to abnormal ovulation, insulin resistance, hyperandrogenemia, and low-grade inflammation in patients with PCOS. Lifestyle intervention, melatonin, vitamin D, and probiotics, etc. were able to improve the pathological mechanism of PCOS via targeting autophagy. In conclusion, autophagy disorder is a key pathological mechanism in PCOS and is also a potential target for drug development and design.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2024) conducted a review in Polycystic Ovary Syndrome (PCOS). Autophagy-targeting therapies (lifestyle intervention, melatonin, vitamin D, probiotics) was evaluated. Autophagy disorder is a key pathological mechanism in polycystic ovary syndrome and serves as a potential target for therapies such as lifestyle intervention, melatonin, vitamin D, and probiotics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: